Dr. Reddy's Laboratories Financial Ratios
NYSE: RDYHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dr. Reddy's Laboratories ratio analysis
Dr. Reddy's Laboratories earned a net margin of 17.4% in FY 2025, down from 19.9% a year earlier. Gross margin was 58.5% compared with a median of 54.2% over the prior 7 years. Return on equity reached 17.0%, meaning Dr. Reddy's Laboratories generated 0.17 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.14 versus 0.07 the year before, and the current ratio was 1.92. At the end of FY 2025, RDY traded at 15.6 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 3.5 to 15.6, with a median of 5.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Dr. Reddy's Laboratories financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 15.65 | 3.66 | 3.45 | 5.97 | 8.25 | 5.28 | 4.94 | 7.18 |
| Price / sales | 2.70 | 3.64 | 3.16 | 0.66 | 0.80 | 0.59 | 0.60 | 0.50 |
| Price / book | 2.64 | 3.63 | 3.36 | 0.74 | 0.88 | 0.66 | 0.66 | 0.56 |
| Gross margin | 58.5% | 58.6% | 56.7% | 53.1% | 54.3% | 53.8% | 54.2% | 53.7% |
| Operating margin | 22.1% | 24.3% | 23.2% | 13.8% | 12.8% | 9.2% | 13.6% | 8.4% |
| Net margin | 17.4% | 19.9% | 18.3% | 11.0% | 9.1% | 11.2% | 12.2% | 6.9% |
| Free cash flow margin | 5.9% | 10.4% | 19.3% | 6.3% | 13.7% | 14.3% | 14.1% | 6.1% |
| Return on equity (ROE) | 17.0% | 19.8% | 19.5% | 12.4% | 10.0% | 12.6% | 13.4% | 7.8% |
| Return on assets (ROA) | 11.5% | 14.4% | 14.0% | 8.1% | 6.5% | 8.4% | 8.3% | 4.4% |
| Debt / equity | 0.14 | 0.07 | 0.06 | 0.18 | 0.17 | 0.14 | 0.27 | 0.40 |
| Current ratio | 1.92 | 2.58 | 2.41 | 1.93 | 1.78 | 1.79 | 1.92 | 1.57 |
| Revenue growth | 13.8% | 12.0% | 5.9% | 8.9% | 12.0% | 4.1% | 2.0% | — |
| EPS growth | -80.3% | 21.5% | 76.5% | 23.0% | -2.6% | -4.9% | 80.2% | — |